Overview

A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

Status:
Recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether radiation therapy given before standard CAR T cell therapy is a safe and effective treatment for people with relapsed and refractory B cell lymphoma. The researchers will also study whether radiation therapy used in this study is a practical treatment option before standard CAR T cell therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center